Different roles of agr1-adrenoceptor subtypes in mediating cardiomyocyte protein synthesis in neonatal rats

Authors: Yongzhen Zhang; Jie Yan; Kai Chen1; Yao Song1; Zhizhen Lu1; Mingzhe Chen1; Chide Han1; Youyi Zhang1

Source: Clinical and Experimental Pharmacology and Physiology, Volume 31, Number 9, September 2004 , pp. 626-633(8)

Publisher: Blackwell Publishing

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

Abstract:

Summary

1. Three different agr1-adrenoceptor subtypes, designated agr1A, agr1B and agr1D, have been cloned and identified pharmacologically in cardiomyocytes. In vitro studies have suggested that agr1-adrenoceptors play an important role in facilitating cardiac hypertrophy. However, it remains controversial as to which subtype of agr1-adrenoceptors is involved in this response. In the present study, we investigated the different role of each agr1-adrenoceptor subtype in mediating cardiomyocyte protein synthesis, which is a most important characteristic of cardiac hypertrophy in cultured neonatal rat cardiomyocytes.

2. Cardiomyocyte hypertrophy was monitored by the following characteristic phenotypic changes: (i) an increase in protein synthesis; (ii) an increase in total protein content; and (iii) an increase in cardiomyocyte size.

3. The role of each agr1-adrenoceptor subtype in mediating cardiomyocyte protein synthesis was investigated by the effect of specific agr1-adrenoceptor subtype-selective antagonists on noradrenaline-induced [3H]-leucine incorporation. In addition, pKB values for agr1-adrenoceptor subtype-selective antagonists were calculated and compared with the corresponding pKi values to further identify their effects.

4. Activation of agr1-adrenoceptors by phenylephrine or noradrenaline in the presence of propranolol significantly increased [3H]-leucine incorporation, protein content and cell size.

5. Pre-incubating cardiomyocytes with 5-methyl-urapidil, RS 17053 or WB 4101 significantly inhibited noradrenaline-induced [3H]-leucine incorporation. However, there was no effect when cardiomyocytes were pre-incubated with BMY 7378. The correlation coefficients between pKB values for agr1-adrenoceptor subtype-selective antagonists and pKi values obtained from cloned agr1A-, agr1B- or agr1D-adrenoceptors were 0.92 (P < 0.01), 0.66 (P > 0.05) and 0.24 (P > 0.05), respectively.

6. Our results suggest that the agr1-adrenoceptor is dominantly responsible for adrenergic hypertrophy of cultured cardiomyocytes in neonatal rats. The efficiency in mediating cardiomyocyte protein synthesis is agr1A > agr1B Gt agr1D.

Keywords: agr1-adrenoceptor; cardiomyocytes; hypertrophy; protein synthesis; subtype

Document Type: Research article

DOI: 10.1111/j.1440-1681.2004.04063.x

Affiliations: 1: Institute of Vascular Medicine, Peking University Third Hospital and Key Laboratory of Molecular Cardiovascular Sciences, Ministry of Education, Beijing, PR China

The full text electronic article is available for purchase. You will be able to download the full text electronic article after payment.

$50.39 plus tax      Refund Policy

 

OR

Back to top

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A